Overview of Neutralizing Antibodies and Their Potential in COVID-19

por Morales-Núñez, José Javier, Muñoz-Valle, José Francisco, Torres-Hernández, Paola Carolina, Hernández-Bello, Jorge
Publicado 2021

Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-C...

por Hernández-Bello, Jorge, Morales-Núñez, José Javier, Machado-Sulbarán, Andrea Carolina, Díaz-Pérez, Saúl Alberto, Torres-Hernández, Paola Carolina, Balcázar-Félix, Paulina, Gutiérrez-Brito, Jesús Alberto, Lomelí-Nieto, José Alvaro, Muñoz-Valle, José Francisco
Publicado 2021

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Pri...

por Morales-Núñez, José Javier, García-Chagollán, Mariel, Muñoz-Valle, José Francisco, Díaz-Pérez, Saúl Alberto, Torres-Hernández, Paola Carolina, Rodríguez-Reyes, Saraí Citlalic, Santoscoy-Ascencio, Guillermo, Sierra García de Quevedo, José Julio, Hernández-Bello, Jorge
Publicado 2022

Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection

por Morales-Núñez, José Javier, Muñoz-Valle, José Francisco, Meza-López, Carlos, Wang, Lin-Fa, Machado Sulbarán, Andrea Carolina, Torres-Hernández, Paola Carolina, Bedolla-Barajas, Martín, De la O-Gómez, Brenda, Balcázar-Félix, Paulina, Hernández-Bello, Jorge
Publicado 2021

Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibod...

por Morales-Núñez, José Javier, Muñoz-Valle, José Francisco, Machado-Sulbarán, Andrea Carolina, Díaz-Pérez, Saúl Alberto, Torres-Hernández, Paola Carolina, Panduro-Espinoza, Beatriz Verónica, Gallegos-Díaz de Leon, Jonathan Adrián, Munguía-Ramirez, Carlos David, Hernández-Bello, Jorge
Publicado 2022